Cancer Genomics
CancerScreenDx™
Multi-Cancer Early Detection
Early detection saves lives. Detect multiple cancers at early stage when they’re most treatable.
Finding cancer early when it is most curable
Early cancer detection significantly improves patient outcomes and reduces treatment burdens. Many cancers remain undiagnosed until advanced stages due to the lack of routine screening. Traditional methods focus on specific cancer types, leaving a gap in comprehensive early detection— especially for high-risk individuals aged 40 or older.
01
Detect over 110 types of cancer
A groundbreaking blood test that detects over 110 types of cancer with a single draw. Unlike routine biomarker tests limited to a few cancers, CancerScreenDx offers broadspectrum analysis, including many not commonly screened.
02
Identify cancer at its earliest stages,
CancerScreenDx empowers patients to take proactive steps when treatment is most effective. Early detection leads to higher survival rates, improved quality of life, and reduced healthcare costs.
03
Forefront of cancer detection innovation
For healthcare systems, integrating CancerScreenDx positions them at the forefront of cancer detection innovation, demonstrating a commitment to advanced patient care and preventative health strategies.
04
Fast & Reliable
Conducted in our ISO 15189 certified lab, with results delivered in just 7–14 working days, ensuring timely decisions for better outcomes.
The Science Behind CancerScreenDx™
All cells, cancer and non-cancer, shed DNA into the bloodstream. As cancer progresses, the proportion of ctDNA in the blood tends to increase, making it a potential biomarker for the detection and monitoring of cancer. The test can detect mutations in the ctDNA that are specific to a particular type of cancer, and by analyzing the mutation patterns, it can predict where in the body the cancer is located. This information can be used to guide the next steps in the diagnostic process, such as selecting the appropriate imaging tests or biopsies.
Any Questions
Transform Cancer Care with Precision Medicine
Our comprehensive genomic profiling tests provide information about clinically relevant biomarkers and genomic alterations to help match patients to approved targeted therapies, immunotherapies, and clinical trial options — giving physicians and patients powerful actionable insights for navigating cancer care.